Regeneron Prescription drugs Inc., the first supplier of the remedies, delivered 135,023 drug doses to U.S. well being care suppliers final week, a ninefold improve from a month earlier, in keeping with knowledge shared by the corporate with The Wall Avenue Journal.
Regeneron estimates that as not too long ago as June, fewer than 5% of high-risk sufferers had been receiving therapy, earlier than rising not too long ago to as a lot as 30%, stated Chief Govt Leonard Schleifer in an interview. The medicine, which have been proven to forestall hospitalizations, are paid for by the federal authorities, and distributed to sufferers freed from cost.
BIDEN PUSHES FOR VACCINE BOOSTER STARTS STARTING IN SEPTEMBER
In January 2021, the federal authorities agreed to pay $2.63 billion for 1.25 million doses, equal to $2,100 per dose of Regeneron‚Äôs drug, which is a cocktail of two antibodies. The contract adopted a earlier settlement in July 2020 through which the U.S. paid $450 million for 300,000 doses.
CLICK HERE FOR COMPLETE CORONAVIRUS COVERAGE
The uptick in demand is being pushed by the surge of infections, particularly within the southern U.S., the place vaccination charges are comparatively low. Some states, together with Florida, Texas and Mississippi, have rushed to broaden antibody-drug infusion facilities and, in some instances, have allowed high-risk sufferers to obtain therapy with out seeing a health care provider first.
Click on right here for extra from the Wall Avenue Journal.